Patent · US Active

Human neonatal Fc receptor antibodies and methods of use thereof

US9359438B2 · kind B2 · utility

5Cited by
32References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 1, 2012
Grant dateJun 7, 2016
Priority date—
Expiry dateJun 21, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure relates to antibodies that bind FcRn and methods of using these antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.